TY - GEN
T1 - Corrigendum to "The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials"
T2 - A meta-analysis of evidence from randomized trials” [J Infect 89 (2024) 106187] (Journal of Infection (2024) 89(1), (S016344532400121X), (10.1016/j.jinf.2024.106187))
AU - Skaarup, Kristoffer Grundtvig
AU - Lassen, Mats Christian Højbjerg
AU - Modin, Daniel
AU - Johansen, Niklas Dyrby
AU - Loiacono, Matthew M
AU - Harris, Rebecca C
AU - Lee, Jason K H
AU - Dufournet, Marine
AU - Vardeny, Orly
AU - Peikert, Alexander
AU - Claggett, Brian
AU - Solomon, Scott D
AU - Jensen, Jens Ulrik Stæhr
AU - Biering-Sørensen, Tor
PY - 2024/11
Y1 - 2024/11
N2 - The authors regret that there is a mistake in the results section (paragraph with subheader “All-cause death”), which incorrectly interprets results presented in the supplementary material. With regards to the relative effect of high-dose vs. standard-dose influenza vaccine against all-cause death, the sentence currently reads: “Positive effects were observed in those free of cardiovascular disease and in individuals aged 65–79 years, respectively statistically significant and insignificant." The correct phrasing should be “respectively statistically non-significant and significant.” The authors would like to apologise for any inconvenience caused.
AB - The authors regret that there is a mistake in the results section (paragraph with subheader “All-cause death”), which incorrectly interprets results presented in the supplementary material. With regards to the relative effect of high-dose vs. standard-dose influenza vaccine against all-cause death, the sentence currently reads: “Positive effects were observed in those free of cardiovascular disease and in individuals aged 65–79 years, respectively statistically significant and insignificant." The correct phrasing should be “respectively statistically non-significant and significant.” The authors would like to apologise for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85203639468&partnerID=8YFLogxK
U2 - 10.1016/j.jinf.2024.106270
DO - 10.1016/j.jinf.2024.106270
M3 - Other contribution
C2 - 39270534
VL - 89
T3 - Journal of Infection
ER -